News >

Landgren Reflects on Recent Breakthroughs in Multiple Myeloma

Caroline Seymour
Published: Tuesday, Jul 30, 2019

C. Ola Landgren, MD, PhD

C. Ola Landgren, MD, PhD
The field of multiple myeloma has seen no shortage of progress in recent years, from new monoclonal antibodies and administrations thereof, to the emergence of targeted therapies for patients with relapsed/refractory disease, explained C. Ola Landgren, MD, PhD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Individualizing Treatment After Second-Line Therapy for Patients With mCRCAug 29, 20191.0
Community Practice Connections™: Immunotherapeutic Strategies with the Potential to Transform Treatment for Genitourinary CancersAug 29, 20191.0
Publication Bottom Border
Border Publication
x